VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
19 hedge funds and large institutions have $862K invested in VIVEVE MED INC in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
19% more funds holding
Funds holding: 16 → 19 (+3)
1.09% more ownership
Funds ownership: 6.05% → 7.15% (+1.1%)
41% less capital invested
Capital invested by funds: $1.46M → $862K (-$601K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$106K |
| 2 |
Millennium Management
New York
|
+$52.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$51.2K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$49.3K |
| 5 |
VF
Virtu Financial
New York
|
+$45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
-$137K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$63K |
| 3 |
Morgan Stanley
New York
|
-$3.47K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.56K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$452 |
VIVE Hedge Fund Activity: Q4 2021 in Review
19 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2021, worth a combined $862K — down 41% from $1.46M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VIVE positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $106K. The largest seller was Meitav Investment House, exiting entirely with an estimated $137K sold.
- 19 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2021, up from 16 in Q3 2021.
- Funds reported $862K of VIVEVE MED INC stock for Q4 2021, down 41% quarter-over-quarter.
- 5 funds opened new VIVEVE MED INC positions in Q4 2021 and 2 closed out, a net change of +3 holders.
- The largest VIVEVE MED INC buyer in Q4 2021 was Renaissance Technologies, an estimated $106K added.
- The largest VIVEVE MED INC seller in Q4 2021 was Meitav Investment House, an estimated $137K sold.
Based on aggregated 13F filings for Q4 2021.